Clinical Studies

Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
NeuroOphthalmology
Obesity/Weight Management
Women's Health
Other


Special Features
Advances/Research

 

Nonablative fractional laser resurfacing for acne scarring in patients with Fitzpatrick skin phototypes IV-VI

Principal Investigator:   Andrew F. Alexis, MD, MPH
Co-principal Investigator:   Marcelyn Coley, MD
Time frame of study:   January 2010- June 2010
Time frame of participation:   5 months
Number of participants needed:   15
Clinical Area this Study Falls Under   Dermatology
Location of Study:   Mount Sinai St. Luke's Roosevelt
Contact name, number and email   Clinical Research Office
(212) 523-4511

Summary:
We are inviting the community to take part in a prospective, split-face, randomized controlled study assessing efficacy and safety of nonablative fractional resurfacing laser treatments for facial acne scarring in patients of color, (skin types IV-VI). The patient will undergo a series of four (4) laser treatments to selected symmetrical affected areas of the face at 4-week intervals. Photographs, surveys, as well as investigator and patient scar assessments will be performed at each visit for a total of 6 visits.

Criteria for Participation:
18 years or older
Desires correctio of acne scarring on face
Patients of color (Fitzpatrick skin types IV-VI)
No laser treatments on face in past 6 months
No discoloration disorders on the face (e.g. vitiligo, melasma)

Benefits and/or Compensation:
Evaluation and treatment by a board-certied dermatologist
FDA approved laser-assisted correction of facial acne scarring at no cost for the procedure